6505-01-341-9964 Acyclovir tablets
One item DLA buys: its open requests for quotation, approved sources and past DLA awards.
Overview
National Stock Number record
- Open RFQs
- 0
- Last price paid
- …
- Standard price
- $41.27 per BT
- DLA's catalog price, not a price paid
- Approved sources
- 3
- Awards on record
- 157
- 2013 to 2026
- DLA demand
- –
Identification
- Item name
- Acyclovir tablets
- FSC / PSC
- 6505 · Drugs and biologicals
- NSG (group)
- 65 · Medical/dental/veterinary eqpt/supp
- NIIN assigned
- 14-JUL-91
- Unit
- BT
- NSN
- 6505-01-341-9964
- NIIN
- 01-341-9964
Name, end product, NIIN date and unit: DLA's Federal Logistics Information System (PUB LOG). Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
Approved suppliers
Manufacturers and suppliers DLA has qualified for this item
| Supplier | CAGE | CAGE status | Part status (RNCC / RNVC) | Supplier part # |
|---|---|---|---|---|
| GOLDEN STATE MEDICAL SUPPLY, INC. | 1HT23 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC51407-0146-01 |
| GLAXO WELLCOME INC DBA | 34006 | A (Active) | 5 (Secondary reference) / 2 (An item-identifying number) | ZOVIRAX |
| TEVA PHARMACEUTICALS USA, INC. | 3V8D7 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC60505-5307-01 |
Source: DLA's approved-source file published with the RFQs. CAGE and part status are FLIS's codes with DLA's wording.
Pricing and awardees
Supply contracts
1 contract DLA ordered this item under
| Award ID | Awardee | Awarding office | Ceiling | Ordering ends | Type | Multiple award | Orders | Last order |
|---|---|---|---|---|---|---|---|---|
| SPE2DX15D0022 | CARDINAL HEALTH, INC. | SPE2DX | $20,000,000 | June 30, 2025 | INDEFINITE DELIVERY / INDEFINITE QUANTITY | No | 3 | July 19, 2018 |
Source: DLA's procurement history files (the contract each order was placed under), the item's newest 2,000 award lines, joined to FPDS by the contract number. Multiple award, ordering period and ceiling are FPDS's; DLA's files do not give them.
Characteristics
Government-defined characteristics of this item (FLIS)
Hazardous and environmental
- Hazardous material (HMIC)
- P (No information in hmirs)
Additional identifiers
- II
- 0
- DEMIL
- A: No demilitarization required
- Precious metals (PMIC)
- A (Does not contain precious metal)
- Schedule B
- 3004909210 (Antiprotozoals, in doses/packagd for retail, nesoi)
- PINC
- 0066753
- Criticality (CRIT CD)
- X
- On FedMall
- Yes
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
Major organizational entity (MOE) rules
How each service or agency buys and manages this item
| Rule | MOE | AMC | AMSC | NIMSC | IMC | AAC | DSOR |
|---|---|---|---|---|---|---|---|
| A911 | Army (DA) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| FSGM | Air Force (DF) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| N9BL | Navy (DN) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). AMC and AMSC wording: DFARS PGI 217.7506. Hover a code for DLA's wording.
Government organizations
The services and agencies that manage or use this item
| Organization | Effective date | Unit of issue | Unit price | Qty per unit | Controlled inventory | Shelf life | Acquisition advice | Source of supply |
|---|---|---|---|---|---|---|---|---|
| Army (DA) | 01-OCT-2025 | BT | $31.55 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Air Force (DF) | 01-OCT-2025 | BT | $31.55 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Navy (DN) | 01-OCT-2025 | BT | $31.55 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| DLA (DS) | 01-OCT-2026 | BT | $41.27 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). Unit prices are DLA's standard prices (its catalog price to its customers, with DLA's surcharge), not prices DLA paid.
DIBBS RFQs
Recent DLA requests for quotation for this item on DIBBS, newest first: 0 open now
| Solicitation | NSN | Item name | Qty | Unit | Std. price | Last price | Est. value | Set-aside | Tech docs | Posted | Return by |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPE2DP27T0081DIBBS only | 6505-01-341-9964 | Acyclovir tablets | 4 | BT | $41.27 per BT | … | … | No set-aside | Yes | October 8, 2026 | October 14, 2026Closed |
→ These RFQs in the DIBBS list
Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
DLA forecast
DLA's purchase forecast for the next 24 months, and its lead time
DLA's own figures
- Lead time
- administrative 15 days, production 113 days (128 in all)
Source: DLA's monthly files in its FOIA reading room: the 24-month demand forecast (what DLA expects to buy, not a commitment) and the ALT/PLT file (administrative lead time: requirement to award; production lead time: award to delivery).
DLA award history
157 award lines since 2013, 5 winning CAGEs
| Winner | Awards | Last award |
|---|---|---|
| 00E55Cardinal Health, Inc. | 152 | July 20, 2024 |
| 0AG09SZY HOLDINGS, LLC | 2 | September 29, 2026 |
| 3W8H0MR UNLIMITED, LLC | 1 | September 3, 2026 |
| 1KA59ARS SALES & SERVICES LLC | 1 | January 26, 2021 |
| 1UNB0DMS PHARMACEUTICAL GROUP INC | 1 | August 25, 2016 |
| Year | Awards | Winning CAGEs |
|---|---|---|
| 2026 | 2 | 2 |
| 2024 | 4 | 2 |
| 2023 | 3 | 1 |
| 2022 | 2 | 1 |
| 2021 | 1 | 1 |
| 2020 | 3 | 1 |
| 2019 | 1 | 1 |
| 2018 | 3 | 1 |
| 2017 | 7 | 1 |
| 2016 | 14 | 2 |
| 2015 | 20 | 1 |
| 2014 | 49 | 1 |
| 2013 | 48 | 1 |
Source: DLA's award history files (its FOIA reading room: every DLA award line since 2013, refreshed monthly), plus the past awards listed in this item's RFQ documents that those files lack. Counts are award lines, not dollars; surplus buys are left out.
DLA awards for this item
25 awards from the item's award history, in FPDS
| Rank | Vendor | Obligated | |
|---|---|---|---|
| 1 | CARDINAL HEALTH, INC. | $5,647 | 54 |
| 2 | DMS PHARMACEUTICAL GROUP INC | $4,425 | 1 |
| 3 | SZY HOLDINGS, LLC | $242 | 1 |
| 4 | ARS SALES & SERVICES LLC | $100 | 1 |
| Contract | Awarded | Awardee | Obligated |
|---|---|---|---|
| SPE2DP25V0552From the item's award history | December 18, 2024 | SZY HOLDINGS, LLC | $242 |
| SPE2D924F3991From the item's award history | July 20, 2024 | CARDINAL HEALTH, INC. | $239 |
| SPE2D924F3799From the item's award history | July 2, 2024 | CARDINAL HEALTH, INC. | $48 |
| SPE2D924F2880From the item's award history | May 8, 2024 | CARDINAL HEALTH, INC. | $80 |
| SPE2D923F2939From the item's award history | April 28, 2023 | CARDINAL HEALTH, INC. | $54 |
| SPE2D923F2376From the item's award history | March 22, 2023 | CARDINAL HEALTH, INC. | $103 |
| SPE2D923F2208From the item's award history | March 15, 2023 | CARDINAL HEALTH, INC. | $103 |
| SPE2D922F2452From the item's award history | April 25, 2022 | CARDINAL HEALTH, INC. | $96 |
| SPE2D922F2028From the item's award history | March 15, 2022 | CARDINAL HEALTH, INC. | $145 |
| SPE2DP21V0510From the item's award history | January 26, 2021 | ARS SALES & SERVICES LLC | $100 |
| SPE2D921F0977From the item's award history | December 25, 2020 | CARDINAL HEALTH, INC. | $48 |
| SPE2D920F3411From the item's award history | June 23, 2020 | CARDINAL HEALTH, INC. | $96 |
| SPE2D920F2622From the item's award history | April 27, 2020 | CARDINAL HEALTH, INC. | $145 |
| SPE2D919F2747From the item's award history | July 1, 2019 | CARDINAL HEALTH, INC. | $295 |
| SPE2D918F4795From the item's award history | July 19, 2018 | CARDINAL HEALTH, INC. | $86 |
| SPE2D918F4498From the item's award history | June 21, 2018 | CARDINAL HEALTH, INC. | $214 |
| SPE2D918F2461From the item's award history | February 17, 2018 | CARDINAL HEALTH, INC. | $86 |
| SPE2DX15D0022/8829From the item's award history | November 17, 2016 | CARDINAL HEALTH, INC. | $86 |
| SPE2DX15D0022/8483From the item's award history | October 24, 2016 | CARDINAL HEALTH, INC. | $43 |
| SPE2DX15D0022/8113From the item's award history | September 13, 2016 | CARDINAL HEALTH, INC. | $75 |
| SPE2DX15D9383/9169From the item's award history | August 25, 2016 | DMS PHARMACEUTICAL GROUP INC | $4,425 |
| SPE2DX15D0022/7797From the item's award history | August 4, 2016 | CARDINAL HEALTH, INC. | $38 |
| SPE2DX15D0022/7769From the item's award history | August 2, 2016 | CARDINAL HEALTH, INC. | $38 |
| SPE2DX15D0022/6473From the item's award history | April 5, 2016 | CARDINAL HEALTH, INC. | $38 |
| SPE2DX15D0022/6333From the item's award history | March 30, 2016 | CARDINAL HEALTH, INC. | $38 |
Showing 1 to 10 of 25 results
Source: DLA award notices on SAM.gov for solicitations that included this item (DLA posts them above $25,000), and the contracts of this item's past DLA awards (DLA's award history files and the RFQs' procurement history), joined to FPDS by contract number (an order under a long-term contract by the order and its contract). Amounts are FPDS obligations; DIBBS order totals are not shown. Department of Defense actions appear in FPDS about 90 days after they are signed.